Changes to diclofenac, fluticasone and cannabis schedules confirmed by TGA The TGA's Advisory Committee on Medicines Scheduling has confirmed earlier decisions to alter the scheduling of a number of widely used medicines. A provisional amendment to the entry for diclofenac, made earlier this year, was confirmed by the ACMS. The revised Schedule 2 entry for diclofenac
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.